JAMA Network Home
Sign In
Viewpoint

Managing Anticancer Drug Spending in Medicare

JAMA Internal Medicine 10.1001/jamainternmed.2025.2898

July 21, 2025 at 11:00 AM EDT

Read the full article

This Viewpoint discusses the Inflation Reduction Act’s drug price negotiation program and how it relates to Medicare spending on anticancer drugs.

Corresponding Author: Stacie B. Dusetzina, PhD, Department of Health Policy, Vanderbilt University School of Medicine, 2525 West End Ave, Ste 1209, Nashville, TN 37203 (s.dusetzina@vanderbilt.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.2898?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072125

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks